Interviewers ask this kind of question to surface how you think, not what you remember. The strongest answers are specific, calmly told, and end on what changed.
Create an account or sign in to see model answers and concept guides, and to track the questions you’ve practiced.
An interim look at your trial suggests a subgroup is seeing serious adverse events, but the signal is early and stopping enrollment would blow the timeline your investors are counting on for the next round. How do you weigh it?
Voice isn’t supported in this browser. Type your answer in the box.
Create a free account to get more critiques.